Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arcturus Therapeutics Holdings Inc. | Director | Common Stock | 3.13K | $100K | $32.03 | Jun 14, 2024 | Direct |
SANGAMO THERAPEUTICS, INC | Director | Common Stock | 71.4K | $42.8K | $0.60 | Jun 4, 2024 | Direct |
Arcturus Therapeutics Holdings Inc. | Director | Deferred Stock Units | 0 | $0 | $32.03 | Jun 14, 2024 | Direct |
SANGAMO THERAPEUTICS, INC | Director | Stock Option (Right to Buy) | 50K | Jun 4, 2024 | Direct | ||
Arcturus Therapeutics Holdings Inc. | Director | Stock option (right to buy) | 15K | Jun 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARCT | Arcturus Therapeutics Holdings Inc. | Jun 14, 2024 | 3 | $0 | 4 | Jun 18, 2024 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
ARCT | Arcturus Therapeutics Holdings Inc. | Aug 1, 2023 | 2 | $0 | 4 | Aug 3, 2023 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Jun 1, 2023 | 2 | $0 | 4 | Jun 5, 2023 | Director |
ARCT | Arcturus Therapeutics Holdings Inc. | Dec 8, 2022 | 2 | $0 | 4 | Dec 13, 2022 | Director |
ARCT | Arcturus Therapeutics Holdings Inc. | Dec 8, 2022 | 0 | $0 | 3 | Dec 13, 2022 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Jun 3, 2022 | 1 | $25K | 4 | Jun 6, 2022 | Director |
SGMO | SANGAMO THERAPEUTICS, INC | Feb 25, 2022 | 2 | $0 | 4 | Mar 1, 2022 | Director |